Combination of tankyrase inhibitors and immune checkpoint inhibitors for anticancer efficacy<br/>

Shiho Tsuruta

[3P-860_3SP-11-02] Combination of tankyrase inhibitors and immune checkpoint inhibitors for anticancer efficacy

^○Shiho Tsuruta^1,2, Tetsuo Mashima¹, Xunmei Yuan¹, Fumiyuki Shirai³, Hiroyuki Seimiya^1,2 (1.Div. Mol. Biother., Cancer Chemother. Ctr., JFCR, 2.CBMS, Grad. Sch. of Frontier Sciences, Univ. of Tokyo, 3.Unit. Drug. Discov., RIKEN CSRS)

This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

The 46th Annual Meeting of the Molecular Biology Society of Japan

[3P-860_3SP-11-02] Combination of tankyrase inhibitors and immune checkpoint inhibitors for anticancer efficacy

Password